Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?

被引:0
作者
Angelena Crown
Shirin Muhsen
Emily C. Zabor
Varadan Sevilimedu
Joanne Kelvin
Shari B. Goldfarb
Mary L. Gemignani
机构
[1] Memorial Sloan Kettering Cancer Center,Breast Service, Department of Surgery
[2] Johns Hopkins International,Clemenceau Medical Center
[3] Cleveland Clinic,Department of Quantitative Health Sciences, Taussig Cancer Institute
[4] Memorial Sloan Kettering Cancer Center,Biostatistics Service, Department of Epidemiology and Biostatistics
[5] Memorial Sloan Kettering Cancer Center,Department of Medicine, Survivorship Center
[6] Memorial Sloan Kettering Cancer Center,Breast Service, Department of Medicine
来源
Annals of Surgical Oncology | 2020年 / 27卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4740 / 4749
页数:9
相关论文
共 179 条
[1]  
Hery C(2008)Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations Ann Oncol. 19 1009-1018
[2]  
Ferlay J(2009)Breast cancer before age 40 years Semin Oncol. 36 237-249
[3]  
Boniol M(2012)Breast cancer incidence trends in European women aged 20–39 years at diagnosis Breast Cancer Res Treat. 134 363-370
[4]  
Autier P(2019)Adolescents and young adults with breast cancer have more aggressive disease and treatment than patients in their forties Ann Surg Oncol. 26 3920-3930
[5]  
Anders CK(2015)Random-start ovarian stimulation in patients with cancer Curr Opin Obstet Gynecol. 27 215-221
[6]  
Johnson R(2016)Mean Age of Mothers is on the Rise: United States, 2000–2014 NCHS data brief. 232 1-8
[7]  
Litton J(2012)Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer Cancer. 118 1933-1939
[8]  
Phillips M(2007)Fertility and adjuvant treatment in young women with breast cancer Breast. 16 S175-S181
[9]  
Bleyer A(2011)Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise Aging (Albany NY). 3 782-793
[10]  
Merlo DF(2015)Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States Cancer. 121 2544-2552